Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M. +30 more·2017·Movement Disorders

DOI 10.1002/mds.27115

Cited by (736)

Items 101–200 of 736

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
О.А. Бунеева, Valerii I. Fedchenko, Arthur Tigranovich Kopylov, A. E. Medvedev · 2020 · Biomedicines
The Role of VPS35 in the Pathobiology of Parkinson’s Disease
Jenny Sassone, Chiara Reale, Giovanna Dati, Maria Regoni, Maria Teresa Pellecchia, Barbara Garavaglia · 2020 · Cellular and Molecular Neurobiology
Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons
Konrad M. Ricke, Thomas Paß, Sammy Kimoloi, Kai Fährmann, Christian Jüngst, Astrid C Schauss, Olivier R. Baris, Marijana Croon, Aleksandra Trifunović, Therese M. Eriksson Faelker et al. · 2020 · Journal of Neuroscience
Gut, oral and nasal microbiota and Parkinson’s disease
Liang Shen · 2020 · Microbial Cell Factories
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
Annekatrin König, Hugo Vicente Miranda, Tiago F. Outeiro · 2018 · Journal of Parkinson s Disease
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
Yakhine-Diop, Sokhna M.S., Morales-García, José A., Niso-Santano, Mireia, González-Polo, Rosa A., Uribe-Carretero, Elisabet, Martinez-Chacon, Guadalupe, Durand, Sylvere, Maiuri, Maria Chiara, Aiastui, Ana, Zulaica, Miren et al. · 2020 · Aging
Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook
Rwei‐Ling Yu, Ruey‐Meei Wu · 2022 · Frontiers in Aging Neuroscience
Pain in Parkinson’s disease and the role of the subthalamic nucleus
A. Mostofi, F. Morgante, M. Edwards, P. Brown, E. Pereira · 2021 · Brain : a journal of neurology
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
Anaïs Marie, Morgane Darricau, Katia Touyarot, Louise C. Parr‐Brownlie, Clémentine Bosch‐Bouju · 2021 · Journal of Parkinson s Disease
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science
Diane T. Stephenson, Robert Alexander, Varun Aggarwal, Reham Badawy, Lisa J. Bain, Roopal Bhatnagar, Bastiaan R. Bloem, Babak Boroojerdi, Jackson K. Burton, Jesse M. Cedarbaum et al. · 2020 · Digital Biomarkers
Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS)
Pablo Martínez‐Martín, Anette E. Schrag, Daniel A. Weintraub, Alexandra Rizos, Carmen Rodríguez‐Blázquez, К. Ray Chaudhuri, on behalf of the IPMDS Non Motor PD Study Group · 2019 · Movement Disorders Clinical Practice
The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine
Peng Chen, Jie Zhang, Chen Wang, Yihui Chai, Anguo Wu, Ning‐yu Huang, Long Wang · 2022 · Phytomedicine
Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases
Luís Sousa, Mariana Guarda, Maria João Meneses, Maria Paula Macedo, Hugo Vicente Miranda · 2021 · The Journal of Pathology
An Update on Medical and Surgical Treatments of Parkinson’s Disease
Dipali Nemade, Thyagarajan Subramanian, Vikram Shivkumar · 2021 · Aging and Disease
Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
Danail Savov Minchev, Maria Kazakova, Victoria Stepan Sarafian · 2022 · International Journal of Molecular Sciences
3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy
Hellen Windolf, Rebecca Chamberlain, Jörg Breitkreutz, Julian Quodbach · 2022 · Pharmaceutics
Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
Kathryn M. Miller, Natosha M. Mercado, Caryl E. Sortwell · 2021 · npj Parkinson s Disease
Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity
Syeda Madiha, Zehra Batool, Saiqa Tabassum, Laraib Liaquat, Sadia Sadir, Sidrah Shahzad, Fizza F. Naqvi, Sadia Saleem, Sarwat Yousuf, Amber Nawaz et al. · 2021 · PLoS ONE
Brain Motor Network Changes in Parkinson’s Disease: Evidence from Meta-Analytic Modeling
D. Herz, David Meder, J. Camilleri, S. Eickhoff, H. Siebner · 2021 · Movement Disorders
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
Nilson Carlos Ferreira‐Junior, Maurício dos Santos Pereira, Francisco Silveira Guimarães, Elaine Del Bel · 2019 · Neurotoxicity Research
Pathogenesis‐targeted therapeutic strategies in Parkinson's disease
Joseph J. Jankovic · 2018 · Movement Disorders
Robust language independent voice data driven Parkinson’s disease detection
Iswarya Kannoth Veetil, V. Sowmya, Juan Rafael Orozco‐Arroyave, E. A. Gopalakrishnan · 2023 · Engineering Applications of Artificial Intelligence
Treatment options for postural instability and gait difficulties in Parkinson’s disease
Martijn L.T.M. Müller, Uroš Marušič, Miriam van Emde Boas, Daniel Weiß, Nicolaas Ida Bohnen · 2019 · Expert Review of Neurotherapeutics
Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson’s Disease
Laura Pelizzari, Maria Marcella Laganà, Sonia Di Tella, Federica Rossetto, Niels Bergsland, Raffaello Nemni, Mario Clerici, Francesca Baglio · 2019 · Frontiers in Aging Neuroscience
Membranes as modulators of amyloid protein misfolding and target of toxicity
Anoop Rawat, Ralf Langen, Jobin Varkey · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal
Tommaso Schirinzi, Marco Canevelli, Antonio Suppa, Matteo Bologna, Luca Marsili · 2020 · Reviews in the Neurosciences
Mild cognitive impairment in Parkinson’s disease
Saül Martínez‐Horta, Jaime Kulisevsky · 2019 · Journal of Neural Transmission
From cell lines to pluripotent stem cells for modelling Parkinson's Disease
Elena Silvia Ferrari, Antonella Cardinale, Barbara Picconi, Fabrizio Gardoni · 2020 · Journal of Neuroscience Methods
Update on the association between alpha‐synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease
Sitong Feng, Zhen‐Zhen Wang, Yu‐He Yuan, Hong‐Mei Sun, Nai‐Hong Chen, Yi Zhang · 2020 · European Journal of Neuroscience
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Khosro Jamebozorgi, Eskandar Taghizadeh, Daryoush Rostami, Hosein Pormasoumi, George Emilio Barreto, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar · 2018 · Molecular Neurobiology
Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson’s Disease Rat Model Through AKT/GSK3β Signaling
Xingzhi Guo, Chang Shan, Yanfang Hou, Geng Zhu, Bei Tao, Li‐hao Sun, Hongyan Zhao, Guang Ning, Sheng‐Tian Li, Jianmin Liu · 2018 · Frontiers in Molecular Neuroscience
Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
Standaert, David G., Childers, Gabrielle M. · 2022 · Proceedings of the National Academy of Sciences
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Maria Angela Samis Zella, Judith Metzdorf, Friederike Ostendorf, Fabian Maass, Siegfried Muhlack, Ralf Gold, Aiden Haghikia, Lars Tönges · 2019 · Cells
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease
Bianca Marchetti · 2020 · Redox Biology
Management of psychiatric disorders in Parkinson's disease
Daniel A. Weintraub · 2020 · Neurotherapeutics
Deregulation of autophagy and vesicle trafficking in Parkinson’s disease
Patricia Sheehan, Zhenyu Yue · 2018 · Neuroscience Letters
The microbiota–gut–brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention
Lidya K. Yassin, Jurga Skrabulyte-Barbulescu, Shamsa H. Alshamsi, Sara Saeed, Shamma H. Alkuwaiti, Saif Almazrouei, Abeer Alnuaimi, Shamsa BaniYas, Dana Aldhaheri, Mahra Alderei et al. · 2025 · Frontiers in Aging Neuroscience
Non-motor symptoms in Parkinson's disease: Opening new avenues in treatment
Shivangi Gupta, Shubha Shukla · 2021 · Current Research in Behavioral Sciences
Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
Ingrid González‐Casacuberta, Diana Luz Juárez‐Flores, Constanza Morén, Glòria Garrabou · 2019 · Frontiers in Neuroscience
A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons
Ghahyun J. Kim, Han Mo, Harrison Liu, Zhihao Wu, Steven Chen, Jiashun Zheng, Xiang Zhao, Daryl Nucum, James Shortland, Longping Peng et al. · 2021 · eLife
Biomarkers of Parkinson’s disease: 20 years later
Rezzak Yılmaz, Franziska Hopfner, Thilo van Eimeren, Daniela Berg · 2019 · Journal of Neural Transmission
Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats
Camila Hillesheim Horst, Franciele Schlemmer, Natália de Aguiar Montenegro, A. Domingues, G. G. Ferreira, Cínthia Yara da Silva Ribeiro, R. R. de Andrade, Elaine Del Bel Guimarães, S. S. Titze-de-Almeida, R. Titze-de-Almeida · 2018 · Neurochemical Research
Glia-derived extracellular vesicles in parkinson’s disease.
Marchetti, Bianca, Leggio, Loredana, L’Episcopo, Francesca, Vivarelli, Silvia, Tirolo, Cataldo, Paternò, Greta, Giachino, Carmela, Caniglia, Salvatore, Serapide, Maria Francesca, Iraci, Nunzio · 2020 · Journal of Clinical Medicine
Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson’s Disease: A Systematic Review
Wote Amelo Rike, Shani Stern · 2023 · International Journal of Molecular Sciences
The Chinese Parkinson's Disease Registry ( CPDR ): Study Design and Baseline Patient Characteristics
Xiaoxia Zhou, Zhenhua Liu, Xiaoting Zhou, Yaqin Xiang, Zhou Zhou, Yuwen Zhao, Hongxu Pan, Qian Xu, Yase Chen, Qiying Sun et al. · 2022 · Movement Disorders
The Role of the Western Diet and Oral Microbiota in Parkinson’s Disease
Barbara Zapała, Tomasz Stefura, Tomasz Milewicz, Julia Wątor, Monika Weronika Piwowar, Magdalena Wójcik-Pędziwiatr, Magdalena Doręgowska, Alicja Dudek, Zuzanna Jania, Monika Rudzińska · 2022 · Nutrients
Parkinson’s Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering
Seung Hyun Lee, Sang‐Min Park, Sang Seok Yeo, Ojin Kwon, Mi‐Kyung Lee, Ho-ryong Yoo, Eun Kyoung Ahn, Jae Young Jang, Jung-Hee Jang · 2022 · Diagnostics
Topographic connectivity and cellular profiling reveal detailed input pathways and functionally distinct cell types in the subthalamic nucleus
H. Jeon, Ho-Jin Lee, D.-H. Kwon, Jiwon Kim, Keiko Tanaka-Yamamoto, J. Yook, Lin-Qing Feng, H. Park, Yong-Hoon Lim, Zang-Hee Cho et al. · 2021 · bioRxiv
Rheumatoid arthritis decreases risk for Parkinson’s disease: a Mendelian randomization study
Chun-Yu Li, R. Ou, H. Shang · 2021 · npj Parkinson's Disease
Focused ultrasound in Parkinson's disease: A twofold path toward disease modification
G. Foffani, I. Trigo-Damas, J. Pineda-Pardo, J. Blesa, R. Rodríguez-Rojas, R. Martínez-Fernández, J. Obeso · 2019 · Movement Disorders
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease
Parekh, Pathik, Serra, Marcello, Allaw, Mohamad, Perra, Matteo, Marongiu, Jacopo, Tolle, Giulia, Pinna, Annalisa, Casu, Maria Antonietta, Manconi, Maria, Caboni, Pierluigi et al. · 2022 · Frontiers in Pharmacology
Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease
Andrea Slézia, Panna Hegedüs, Evgeniia Rusina, Katalin Lengyel, Nicola Solari, Attila Kaszás, Diána Balázsfi, Boris Botzanowski, Emma Acerbo, Florian Missey et al. · 2023 · Scientific Reports
Neuroprotective potential of formononetin, a naturally occurring isoflavone phytoestrogen
Lovedeep Singh, Harpreet Kaur, Girish Chandra Arya, Rajbir Bhatti · 2023 · Chemical Biology & Drug Design
Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
Francisco Javier Padilla-Godínez, Leonardo Ibor Ruiz-Ortega, Magdalena Guerra‐Crespo · 2022 · Cells
Re-Analysis of the STEADY-PD II Trial—Evidence for Slowing the Progression of Parkinson’s Disease
D. J. Surmeier, J. Nguyen, Nicola Lancki, C. Venuto, D. Oakes, T. Simuni, Richard K. Wyse · 2021 · Movement Disorders
Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus
Thomas Paß, Rudolf J. Wiesner, David Pla‐Martín · 2021 · Frontiers in Molecular Biosciences
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis
Maria Francesca Serapide, Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Carmela Giachino, Bianca Marchetti · 2020 · Frontiers in Aging Neuroscience
The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Alexander Kilzheimer, Thomas Hentrich, Simone Burkhardt, Julia Maria Schulze-Hentrich · 2019 · Frontiers in Neurology
Oxidative phosphorylation mediated pathogenesis of Parkinson's disease and its implication via Akt signaling
MD. Zainul Ali, Pankaj Singh Dholaniya · 2022 · Neurochemistry International
Therapeutic Potential of Astrocyte Transplantation
Nataly Hastings, Wei‐Li Kuan, Andrew Osborne, Mark Kotter · 2022 · Cell Transplantation
Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic review
Christiane Oedekoven, Leonie Egeri, Frank Jessen, Michael Wagner, Richard C. Dodel · 2021 · Ageing Research Reviews
Baroreflex dysfunction in Parkinson’s disease: integration of central and peripheral mechanisms
Jeann L. Sabino‐Carvalho, Bárbara Falquetto, Ana Carolina Thomaz Takakura, Lauro Casqueiro Vianna · 2021 · Journal of Neurophysiology
Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
Ifat Alsharif, Loubna Boukhzar, Benjamin Lefranc, David Godefroy, Juliette Aury‐Landas, Jean Luc do Rego, Jean-Claude do-Rego, Frédéric Naudet, Arnaud Arabo, Abdeslam Chagraoui et al. · 2020 · Redox Biology
Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury
Jun Hua, Nuo Yin, Shi Xu, Qiang Chen, Tingting Tao, Ji Zhang, Jianhua Ding, Yi Fan, Gang Hu · 2019 · Cellular and Molecular Neurobiology
Diagnostic utility of gut α-synuclein in Parkinson’s disease: A systematic review and meta-analysis
Jin Bu, Jinsong Liu, Kun Liu, Zhaohui Wang · 2019 · Behavioural Brain Research
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Jinfan Li, Dong Li, Yajie Chen, Wenbin Chen, Jin Xu, Ling Gao · 2023 · Clinical Interventions in Aging
Brain-enriched miR-128: Reduced in exosomes from Parkinson’s patient plasma, improves synaptic integrity, and prevents 6-OHDA mediated neuronal apoptosis
Pallabi Bhattacharyya, Atanu Biswas, Subhas Chandra Biswas · 2023 · Frontiers in Cellular Neuroscience
Pragmatism and the Importance of Interdisciplinary Teams in Investigating Personality Changes Following DBS
Cynthia S. Kubu, Paul J. Ford, Joshua Adam Wilt, Amanda R. Merner, Michelle M. Montpetite, Jaclyn Zeigler, Éric Racine · 2019 · Neuroethics
Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
Flora J. Ferreira, M. Gago, E. Bicho, Catarina Carvalho, N. Mollaei, L. Rodrigues, N. Sousa, P. Rodrigues, Carlos Ferreira, João Gama · 2019 · Journal of Biomechanics
Calcium Deregulation in Neurodegeneration and Neuroinflammation in Parkinson’s Disease: Role of Calcium-Storing Organelles and Sodium–Calcium Exchanger
Guendalina Bastioli, Silvia Piccirillo, Laura Graciotti, Marianna Carone, Giorgia Sprega, Omayema Taoussi, Alessandra Preziuso, Pasqualina Castaldo · 2024 · Cells
An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks
Iswarya Kannoth Veetil, Divi Eswar Chowdary, Paleti Nikhil Chowdary, V. Sowmya, E. A. Gopalakrishnan · 2024 · Digital Signal Processing
Mechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease
Diptaman Chatterjee, Dimitri Krainc · 2023 · Journal of Molecular Biology
Animal Models of Parkinson’s Disease: Are They Useful or Not?
R. Barker, A. Björklund · 2020 · Journal of Parkinson's Disease
Parkinson’s Disease in the Era of Personalised Medicine: One Size Does Not Fit All
Lauren E. Ryden, Simon J.G. Lewis · 2018 · Drugs & Aging
Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
Xin Cui, Xinwei Li, Huimin Zheng, Yun Su, Shuyu Zhang, Mengjie Li, Xiaoyan Hao, Shuo Zhang, Zhengwei Hu, Zongping Xia et al. · 2024 · npj Parkinson s Disease
Enhancing Parkinson's disease severity assessment through voice-based wavelet scattering, optimized model selection, and weighted majority voting
Farhad Abedinzadeh Torghabeh, Seyyed Abed Hosseini, Elham Ahmadi Moghadam · 2023 · Medicine in Novel Technology and Devices
The return of the lesion for localization and therapy
Juho Joutsa, Nir Lipsman, Andreas Horn, Garth Rees Cosgrove, Michael D Fox · 2023 · Brain
Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
Jing-Ru Ren, Lanting Li, Rong-Gui Zhang, Chenxi Pan, Jian-Xia Xu, H. Sun, Ping Hua, Li Zhang, Wen-Bin Zhang, Ping-Yi Xu et al. · 2021 · European Journal of Neurology
Autophagy in α-Synucleinopathies—An Overstrained System
Lisa Fellner, Elisa Gabassi, Johannes Haybaeck, Frank Edenhofer · 2021 · Cells
The neuromicrobiology of Parkinson’s disease: A unifying theory
Mario Muñoz, Nuno Empadinhas, Sandra M. Cardoso · 2021 · Ageing Research Reviews
Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19
Sreus A. G. Naidu, Taylor C. Wallace, Kelvin J.A. Davies, A. Satyanarayan Naidu · 2021 · Journal of Dietary Supplements
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
Loredana Leggio, Greta Paternò, Silvia Vivarelli, Francesca L’Episcopo, Cataldo Tirolo, Gabriele Raciti, Fabrizio Pappalardo, Carmela Giachino, Salvatore Caniglia, Maria Francesca Serapide et al. · 2020 · Biomolecules
Altered baseline and amphetamine-mediated behavioral profiles in dopamine transporter Cre (DAT-Ires-Cre) mice compared to tyrosine hydroxylase Cre (TH-Cre) mice
Muhammad O. Chohan, Sari Esses, Julia Haft, Susanne E. Ahmari, Jeremy M. Veenstra-VanderWeele · 2020 · Psychopharmacology
Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease
Katharina A. Schindlbeck, Olaia Lucas‐Jiménez, Chris C. Tang, Silvia Daniela Morbelli, Dario Arnaldi, Matteo Pardini, Marco Pagani, Naroa Ibarretxe‐Bilbao, Natalia Ojeda, Flavio Mariano Nobili et al. · 2019 · Movement Disorders
Journal of Neurochemistry: Issue Information
L. Correia-Guedes, T. Mestre, T. Outeiro, Joauqim J. Ferreira · 2019 · Journal of Neurochemistry
Dendrimers in Neurodegenerative Diseases
María Dolores Pérez‐Carrión, Inmaculada Posadas · 2023 · Processes
Sinapic Acid Protects SH-SY5Y Human Neuroblastoma Cells against 6-Hydroxydopamine-Induced Neurotoxicity
Tsendsuren Tungalag, Dong Kwon Yang · 2021 · Biomedicines
Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening
Cristian Zanetti, Sarah Spitz, Emanuel Berger, Silvia Bolognin, Lisa M. Smits, Philipp Crepaz, Mario Rothbauer, Julie M. Rosser, Martina Marchetti‐Deschmann, Jens Christian Schwamborn et al. · 2021 · The Analyst
Comprehensive Perspectives on Experimental Models for Parkinson’s Disease
Minjing Ke, Cheong‐Meng Chong, Qi Zhu, Ke Zhang, Cui-Zan Cai, Jiahong Lu, Dajiang Qin, Huanxing Su · 2021 · Aging and Disease
The PPARGC1A locus and CNS-specific PGC-1α isoforms are associated with Parkinson's Disease
Selma M. Soyal, Greta Zara, Boris Ferger, Thomas Klaus Felder, Markus Kwik, Charity Nofziger, Silvia Dossena, Christine Schwienbacher, Andrew A. Hicks, Peter Paul Pramstaller et al. · 2018 · Neurobiology of Disease
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Alessandro Tozzi, Valentina Durante, Guendalina Bastioli, Petra Mazzocchetti, Salvatore Novello, Alessandro Mechelli, Michele Morari, Cinzia Costa, Andrea Mancini, Massimiliano Di Filippo et al. · 2018 · Neurobiology of Disease
An intensive neurorehabilitation programme with sEMG biofeedback to improve swallowing in idiopathic Parkinson's disease (IPD): A feasibility study.
Irene Battel, M. Walshe · 2022 · International journal of language and communication disorders
Effects of Ten Different Exercise Interventions on Motor Function in Parkinson’s Disease Patients—A Network Meta-Analysis of Randomized Controlled Trials
Zikang Hao, Xiaodan Zhang, Ping Chen · 2022 · Brain Sciences
Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes
Cecilia Boccalini, Giulia Carli, Andrea Pilotto, Alessandro Padovani, Daniela Perani · 2022 · Neurobiology of Disease
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
Christopher A. Simon, Tomoko Soga, Hirotaka James Okano, Ishwar S. Parhar · 2021 · Cell & Bioscience
Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?
N. Ortner · 2021 · Frontiers in Synaptic Neuroscience
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia
Valeria Calabrese, A. di Maio, G. Marino, A. Cardinale, G. Natale, Arianna De Rosa, F. Campanelli, M. Mancini, F. Napolitano, L. Avallone et al. · 2020 · Frontiers in Aging Neuroscience
Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Mohammad Dehestani, Velina Kozareva, Cornelis Blauwendraat, Ernest Fraenkel, Thomas Gasser, Vikas Bansal · 2024 · Molecular Brain
Suppression of neuroinflammation and α-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson's disease
Yea‐Hyun Leem, Jin‐Sun Park, Jung-Eun Park, Doyoun Kim, Hee-Sun Kim · 2023 · Neurochemistry International